Arrowstreet Capital’s Chemed CHE Stock Holding History

Arrowstreet Capital’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$77.4M	Buy	166,149 +13,680	+9%	+$5.75M	0.03%	420
2026 Q1	$57.6M	Sell	152,469 -2,050	-1%	-$878K	0.03%	456
2025 Q4	$66.1M	Buy	154,519 +58,946	+62%	+$25.7M	0.04%	393
2025 Q3	$42.8M	Buy	95,573 +84,208	+741%	+$38.1M	0.03%	505
2025 Q2	$5.53M	Buy	11,365 +4,560	+67%	+$2.6M	﹤0.01%	1131
2025 Q1	$4.19M	Buy	+6,805	New	+$3.87M	﹤0.01%	1074
2021 Q2	–	Sell	-8,500	Closed	-$3.91M	–	1919
2021 Q1	$3.91M	Buy	8,500 +7,400	+673%	+$3.63M	0.01%	1287
2020 Q4	$586K	Buy	+1,100	New	+$540K	﹤0.01%	1975
2017 Q3	–	Sell	-4,600	Closed	-$941K	–	1115
2017 Q2	$941K	Buy	+4,600	New	+$916K	﹤0.01%	795

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Arrowstreet Capital's CHE Position: Q2 2026 in Review

Arrowstreet Capital increased its Chemed (CHE) stake by 9% in Q2 2026, buying an estimated $5.75M and bringing the position to 166,149 shares worth $77.4M. The position accounts for 0.03% of the portfolio, ranked #420.

Arrowstreet Capital first reported a position in CHE in Q2 2017 and has held it in 9 quarters since. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

Arrowstreet Capital held 166,149 shares of Chemed worth $77.4M as of Q2 2026.
Arrowstreet Capital bought 13,680 Chemed shares in Q2 2026, an estimated $5.75M.
Chemed made up 0.03% of Arrowstreet Capital's portfolio in Q2 2026, its #420 holding.
Arrowstreet Capital first reported a position in Chemed in Q2 2017 and has held it in 9 quarters since.
530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.